Our day-to-day at Memorias del IICS

A glimpse into our day-to-day at the Memorias del IICS office

Leer más

About

Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud) is the official publication of the Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA), Paraguay. It publishes original scientific contributions in clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. Founded in 1983, the journal adopted its current name in 2002 and has been published exclusively online since 2015, incorporating XML article dissemination as of 2024. Since 2023, it operates under a continuous publication model. The journal accepts manuscripts in Spanish and English as original research articles, reviews, case studies, and brief communications. All content is available in open access, free of charge for authors and readers, under the Creative Commons Attribution 4.0 International License, in accordance with the Budapest Open Access Initiative (BOAI). It is indexed in BVS, SciELO Paraguay, HINARI, LILACS, DOAJ, Latindex, MIAR, Dialnet, CiteFactor, Google Scholar, LivRe, BASE, EBSCO, and Web of Science – SciELO Citation Index. The journal is funded by IICS-UNA, supports the OAI-PMH protocol for metadata harvesting, and uses the LOCKSS system for digital preservation of its contents.

 
Leer más

Peer Review Process

Manuscripts submitted to Memorias del Instituto de Investigaciones en Ciencias de la Salud undergo a double-blind peer review process, in which the identities of both authors and reviewers remain anonymous throughout the evaluation. Each manuscript is assessed by a minimum of two external reviewers with expertise in the relevant subject area, who are given a period of 30 days to submit their evaluation. Reviewers assess the originality, methodological rigor, scientific relevance, and clarity of presentation of each work. Based on the reviewers' reports, the Editorial Committee decides whether to accept, request revisions, or reject the manuscript, and communicates the decision to the authors as promptly as possible. This process ensures impartiality, transparency, and the scientific quality of published articles.

Leer más

Call for Papers

The Institute of Research in Health Sciences (IICS) of the National University of Asunción (UNA) invites researchers, academics, and health professionals to submit their manuscripts for consideration in the 2026 Volume of Memorias del Instituto de Investigaciones en Ciencias de la Salud (Mem. Inst. Investig. Cienc. Salud). The journal accepts original and unpublished contributions in Spanish as original research articles, review articles, case studies, and brief communications, in the areas of clinical medicine, biomedical research, microbiology, molecular biology, dentistry, nursing, nutrition, public health, health biotechnology, genetics, biochemistry, and related disciplines. The call for submissions is open and ongoing, and manuscripts may be submitted at any time of the year through the journal's online submission system. All received manuscripts undergo double-blind peer review. The journal is open access, with no charges for authors or readers. For further information on submission guidelines, please refer to the author instructions available on the journal's website.

Leer más

Síndrome Metabólico en pacientes con psoriasis de la Cátedra de Dermatología del Hospital de Clínicas

Authors

  • Claudia Contreras
  • B Di Martino Ortiz Author
  • M Rodríguez Masi Author
  • Oilda Knopfelmacher Author
  • Lourdes Bolla de Lezcano Author
  • Margarita Samudio Author

Keywords:

hipertensión arterial, dislipidemia, insulinorresistencia, obesidad, psoriasis, síndrome metabólico

Abstract

La psoriasis es una enfermedad inflamatoria crónica sistémica de la piel. Publicaciones de los últimos 10 años reportan una asociación entre la psoriasis y el síndrome metabólico, una agrupación de factores de riesgo que incluye la obesidad, hipertensión arterial, dislipidemia e insulinorresistencia. El objetivo del presente trabajo fue determinar la frecuencia del síndrome metabólico y las características clínicas de los pacientes con psoriasis. Para ello, se realizó un estudio observacional descriptivo de corte trasversal en pacientes con psoriasis que consultaron en la Cátedra de Dermatología del Hospital de Clínicas de mayo a diciembre del año 2013. Se estudiaron 52 pacientes con psoriasis, de los cuales 36 pacientes (69%) eran de sexo masculino. Presentaron síndrome metabólico 25 casos (48%), la hipertensión arterial fue el factor de riesgo más frecuente estando presente en 31 pacientes (60%), siguiéndole en frecuencia la obesidad en 31 pacientes (58%). Se encontró que tanto el síndrome metabólico como todos sus componentes en forma individual son más frecuentes en los pacientes con psoriasis moderada y severa. El síndrome metabólico es un hallazgo frecuente en los pacientes con psoriasis existiendo una relación directa entre la severidad de la psoriasis con el síndrome metabólico y cada uno de los factores de riesgo que lo componen, por lo cual se hace imperativa la búsqueda de esta patología en la evaluación dermatológica clínica para la prevención de complicaciones cardiovasculares.

Downloads

Download data is not yet available.

References

Armstrong A, Harskamp C, Armstrong E. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies. J Am Acad Dermatol. 2013; 68(4):654-59.

Gelfand JM, Yeung H. Metabolic syndrome in patiens with psoriatic disease. J Rheumatol Suppl. 2012; 89:24-8.

Padhi T. Metabolic syndrome and skin: Psoriasis and Beyond. Indian J Dermatol. 2013; 58(4): 299–305.

Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in South Indian patients with psoriasis vulgaris and the relation between disease severity and metabolic syndrome: a hospital-based case-control study. Indian J Dermatol. 2012; 57(5): 353-7.

Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288:2709–16.

Rosas Guzmán J, González Chávez A, Aschner P, Bastarrachea R, editores. Consenso latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD): Epidemiología, diagnóstico, control, prevención y tratamiento del síndrome metabólico en adultos. Rev ALAD. 2010; 18(1):25-42.

Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002; 287(3): 356-9.

Giovanucci E. Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr. 2007; 86(3): 836S-42S.

Friedewald VE, Cather JC, Gelfand KB, Gibbons GH, Grudy SM, Jarratt MT, et al. AJC editor´s consensus: psoriasis and coronary artery disease. Am J Cardiol. 2008;102(12): 1631-43.

National Cholesterol Education Program (NCEP). Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Final report. Circulation. 2002; 106(25):3143–421.

Carbo Amoroso E, Leban V, Federico D, Williner ME, Díaz MG, Guardati MV, et al. Psoriasis y síndrome metabólico: Estudio retrospectivo sobre 22 casos. Rev. argent. Dermatol. 2010; 91(1):00-00.

Guimarães I, Vasques F, Gontijo B, Andrade E. Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol. 2014 Sep-Oct; 89(5): 735–44.

Hulley S, Cummings S, Browner W, Grady D, Newman T. Diseño de investigaciones clínicas. 3ª ed. Barcelona: Lippincott Williams & Wilkins; 2008.

Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002. Dermatology. 2008; 217(1): 27–37.

Love TJ, Qureshi AA, Karlson EW, Gelfand JM, Choi H. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol. 2011; 147(4): 419-24.

Topic I, Simic D. Prevalence of metabolic syndrome in patients with psoriasis at Mostar Clinical Hospital. Acta Clin Croat. 2013; 52(1): 53-8.

Votrubova J, Juzlova K, Smerhovsky Z, Fialova J, Gopfertova D, Vojackova N, Hercogova J. Risk factors for comorbidities in Czech psoriatic patients: results of a hospital-based case-control study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014; 158(2):288-94.

Azfara RS, Gelfand JM. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol. 2008; 20(4): 416–22.

Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, et al. National Psoriasis Foundation clinical consensus on psoriasis comorbilities and recommendations for screening. J Am Acad Dermatol. 2008; 58(6):1031-42.

Mehta NN, Yu Y, Pinnelas R, Krishnamoorthy P, Shin DB, Troxel AB, Gelfand JM. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med. 2011; 124(8):775, e1–6.

Torres T, Sales R, Vasconcelos C, Selores M. [Psoriasis and cardiovascular disease]. Acta Med Port. 2013; 26(5):601-7.

Van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, Schouten JN, Nijsten T. Psoriasis is independently associated with nonalcolholic fatty liver disease in patients 55 years old or older: Reslults from a population-based study. J Am Acad Dermatol. 2014; 70(3): 517-24.

Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol. 2012; 132(3 Pt 1):556-62.

Channual J, Wu JJ, Dann FJ. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatol Ther. 2009; 22(1): 61–73.

Downloads

Published

2014-12-01

Issue

Vol. 12 No. 2 (2014): Julio-Diciembre

Section

Original Articles

How to Cite

Contreras, C., Di Martino Ortiz, B., Rodríguez Masi, M., Knopfelmacher, O., Bolla de Lezcano, L., & Samudio, M. (2014). Síndrome Metabólico en pacientes con psoriasis de la Cátedra de Dermatología del Hospital de Clínicas. Memorias Del Instituto De Investigaciones En Ciencias De La Salud, 12(2). https://revistascientificas.una.py/index.php/RIIC/article/view/1779